Titre : Version foetale

Version foetale : Questions médicales fréquentes

Termes MeSH sélectionnés :

Neonatal Screening
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Version foetale : Questions médicales les plus fréquentes", "headline": "Version foetale : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Version foetale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Version foetale" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Accouchement (procédure)", "url": "https://questionsmedicales.fr/mesh/D036861", "about": { "@type": "MedicalCondition", "name": "Accouchement (procédure)", "code": { "@type": "MedicalCode", "code": "D036861", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E04.520.252" } } }, "about": { "@type": "MedicalCondition", "name": "Version foetale", "alternateName": "Version, Fetal", "code": { "@type": "MedicalCode", "code": "D014710", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "You Jung Han", "url": "https://questionsmedicales.fr/author/You%20Jung%20Han", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Jin Hoon Chung", "url": "https://questionsmedicales.fr/author/Jin%20Hoon%20Chung", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Moon Young Kim", "url": "https://questionsmedicales.fr/author/Moon%20Young%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea." } }, { "@type": "Person", "name": "Min Hyoung Kim", "url": "https://questionsmedicales.fr/author/Min%20Hyoung%20Kim", "affiliation": { "@type": "Organization", "name": "Department of Obstetrics and Gynecology, Gangseo Mizmedi Hospital, Seoul, Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Neonatal Hyperbilirubinemia.", "datePublished": "2022-06-01", "url": "https://questionsmedicales.fr/article/35667102", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/19382359-20220407-02" } }, { "@type": "ScholarlyArticle", "name": "Retrospective analysis of reference intervals for dried blood spot based ms/ms newborn screening programs in Chinese preterm neonates: a nationwide study.", "datePublished": "2024-07-02", "url": "https://questionsmedicales.fr/article/38956494", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-024-04865-1" } }, { "@type": "ScholarlyArticle", "name": "Genomic newborn screening: Are we entering a new era of screening?", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37403863", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jimd.12650" } }, { "@type": "ScholarlyArticle", "name": "Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening.", "datePublished": "2023-09-05", "url": "https://questionsmedicales.fr/article/37656460", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.31162" } }, { "@type": "ScholarlyArticle", "name": "Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategies.", "datePublished": "2022-06-25", "url": "https://questionsmedicales.fr/article/35751446", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/aos.15205" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Procédures de chirurgie opératoire", "item": "https://questionsmedicales.fr/mesh/D013514" }, { "@type": "ListItem", "position": 3, "name": "Procédures de chirurgie obstétrique", "item": "https://questionsmedicales.fr/mesh/D013513" }, { "@type": "ListItem", "position": 4, "name": "Accouchement (procédure)", "item": "https://questionsmedicales.fr/mesh/D036861" }, { "@type": "ListItem", "position": 5, "name": "Version foetale", "item": "https://questionsmedicales.fr/mesh/D014710" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Version foetale - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Version foetale", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Version foetale", "description": "Comment diagnostiquer une présentation en siège ?\nQuels signes indiquent une version fœtale ?\nQuand effectuer une échographie pour la version fœtale ?\nQuels examens préalables à la version fœtale ?\nPeut-on détecter une version fœtale par palpation ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Version foetale", "description": "Quels symptômes peuvent indiquer un siège fœtal ?\nY a-t-il des douleurs associées à la version fœtale ?\nComment se manifeste un fœtus en siège ?\nQuels signes de détresse fœtale peuvent apparaître ?\nLes contractions sont-elles différentes en cas de siège ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Version foetale", "description": "Peut-on prévenir un siège fœtal ?\nLes exercices peuvent-ils aider à la position fœtale ?\nLe yoga peut-il influencer la position fœtale ?\nLes positions de sommeil affectent-elles la version ?\nLes visites régulières chez le médecin sont-elles importantes ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Version foetale", "description": "Comment se déroule une version fœtale ?\nQuels sont les risques de la version fœtale ?\nQuand est-il préférable de ne pas faire de version fœtale ?\nQuels médicaments peuvent être utilisés lors de la version ?\nLa version fœtale est-elle toujours efficace ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Version foetale", "description": "Quelles complications peuvent survenir après une version ?\nLa version fœtale peut-elle entraîner une césarienne ?\nQuels sont les signes d'une complication post-version ?\nLes complications sont-elles fréquentes après une version ?\nComment gérer les complications après une version ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Version foetale", "description": "Quels facteurs augmentent le risque de siège fœtal ?\nL'âge maternel influence-t-il la position fœtale ?\nLes anomalies utérines affectent-elles la version fœtale ?\nLe tabagisme maternel influence-t-il la position fœtale ?\nLes antécédents de césarienne influencent-ils la version ?", "url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Neonatal+Screening&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une présentation en siège ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie et l'examen pelvien permettent de confirmer la présentation en siège." } }, { "@type": "Question", "name": "Quels signes indiquent une version fœtale ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Une palpation abdominale révèle la position du fœtus et des mouvements anormaux." } }, { "@type": "Question", "name": "Quand effectuer une échographie pour la version fœtale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une échographie est recommandée vers la 36e semaine de grossesse pour évaluer la position." } }, { "@type": "Question", "name": "Quels examens préalables à la version fœtale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un examen clinique et une échographie sont nécessaires pour évaluer les risques." } }, { "@type": "Question", "name": "Peut-on détecter une version fœtale par palpation ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la palpation abdominale permet d'évaluer la position du fœtus." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un siège fœtal ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une sensation de pression dans le bas-ventre et des mouvements fœtaux anormaux." } }, { "@type": "Question", "name": "Y a-t-il des douleurs associées à la version fœtale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales peuvent survenir lors de la manœuvre de version." } }, { "@type": "Question", "name": "Comment se manifeste un fœtus en siège ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le fœtus en siège peut provoquer des douleurs lombaires et une pression pelvienne." } }, { "@type": "Question", "name": "Quels signes de détresse fœtale peuvent apparaître ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution des mouvements fœtaux ou des anomalies du rythme cardiaque." } }, { "@type": "Question", "name": "Les contractions sont-elles différentes en cas de siège ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les contractions peuvent être plus intenses et moins régulières avec un fœtus en siège." } }, { "@type": "Question", "name": "Peut-on prévenir un siège fœtal ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode garantie pour prévenir un siège fœtal, mais un suivi régulier aide." } }, { "@type": "Question", "name": "Les exercices peuvent-ils aider à la position fœtale ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Certains exercices de positionnement peuvent encourager le fœtus à se retourner." } }, { "@type": "Question", "name": "Le yoga peut-il influencer la position fœtale ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Le yoga prénatal peut aider à améliorer la flexibilité et favoriser une meilleure position." } }, { "@type": "Question", "name": "Les positions de sommeil affectent-elles la version ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Dormir sur le côté gauche peut favoriser une meilleure circulation et position fœtale." } }, { "@type": "Question", "name": "Les visites régulières chez le médecin sont-elles importantes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles permettent de surveiller la position fœtale et d'anticiper les complications." } }, { "@type": "Question", "name": "Comment se déroule une version fœtale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La version fœtale est réalisée par un obstétricien, souvent sous échographie et anesthésie." } }, { "@type": "Question", "name": "Quels sont les risques de la version fœtale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent la rupture des membranes, la détresse fœtale et des saignements." } }, { "@type": "Question", "name": "Quand est-il préférable de ne pas faire de version fœtale ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "En cas de placenta praevia, de malformations fœtales ou de complications maternelles." } }, { "@type": "Question", "name": "Quels médicaments peuvent être utilisés lors de la version ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des tocolytiques peuvent être administrés pour détendre l'utérus pendant la manœuvre." } }, { "@type": "Question", "name": "La version fœtale est-elle toujours efficace ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La version fœtale réussit dans environ 50-70% des cas, selon la situation clinique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une version ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements, des contractions prématurées ou une détresse fœtale peuvent survenir." } }, { "@type": "Question", "name": "La version fœtale peut-elle entraîner une césarienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, si la version échoue ou si des complications surviennent, une césarienne peut être nécessaire." } }, { "@type": "Question", "name": "Quels sont les signes d'une complication post-version ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs abdominales intenses, des saignements ou une diminution des mouvements fœtaux." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes après une version ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares, mais un suivi médical est essentiel après la procédure." } }, { "@type": "Question", "name": "Comment gérer les complications après une version ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical étroit et des interventions appropriées sont nécessaires pour gérer les complications." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de siège fœtal ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les grossesses multiples, l'anatomie pelvienne et les antécédents de siège augmentent le risque." } }, { "@type": "Question", "name": "L'âge maternel influence-t-il la position fœtale ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes plus âgées peuvent avoir un risque accru de présentation en siège." } }, { "@type": "Question", "name": "Les anomalies utérines affectent-elles la version fœtale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anomalies utérines peuvent limiter la capacité du fœtus à se positionner correctement." } }, { "@type": "Question", "name": "Le tabagisme maternel influence-t-il la position fœtale ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut affecter le développement fœtal et augmenter le risque de siège." } }, { "@type": "Question", "name": "Les antécédents de césarienne influencent-ils la version ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents de césarienne peuvent compliquer la version fœtale et augmenter les risques." } } ] } ] }

Sources (10000 au total)

Retrospective analysis of reference intervals for dried blood spot based ms/ms newborn screening programs in Chinese preterm neonates: a nationwide study.

Although recent discoveries regarding the biomarkers of newborn screening (NBS) programs by tandem mass spectrometry (MS/MS) highlight the critical need to establish reference intervals (RIs) specific... The NBS data of 199,693 preterm newborns (< 37 weeks of gestation) who met the inclusion and exclusion criteria from the NNSCP database were included in study analysis. The birth weight stratified dyn... Increasing birth weight is associated with an elevation in the levels of arginine, citrulline, glycine, leucine and isobarics, methionine, ornithine, phenylalanine, and valine, whereas the levels of a... The current study developed reference intervals (RIs) specific to birth weight, age, and/or sex for 35 MS/MS biomarkers, which can help in the timely evaluation of the health and disease of preterm ne...

Genomic Sequencing as a First-Tier Screening Test and Outcomes of Newborn Screening.

Newborn screening via biochemical tests is in use worldwide. The availability of genetic sequencing has allowed rapid screening for a substantial number of monogenic disorders. However, the outcomes o... To evaluate the outcomes of applying gene panel sequencing as a first-tier newborn screening test.... This cohort study included newborns who were prospectively recruited from 8 screening centers in China between February 21 and December 31, 2021. Neonates with positive results were followed up before... All participants were concurrently screened using dried blood spots. The screen consisted of biochemical screening tests and a targeted gene panel sequencing test for 128 conditions. The biochemical a... The primary outcomes were the number of patients detected by gene panel sequencing but undetected by the biochemical test.... This study prospectively recruited 29 601 newborns (15 357 [51.2%] male). The mean (SD) gestational age was 39.0 (1.5) weeks, and the mean (SD) birth weight was 3273 (457) g. The gene panel sequencing... In this cohort study, the use of gene panel sequencing in a general newborn population as a first-tier screening test improved the detection capability of traditional screening, providing an evidence-...

Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategies.

Evaluate possibilities to reduce the number of infants screened for retinopathy of prematurity (ROP) and investigate costs and number of infants detected of current and alternative screening strategie... Prospective population-based study including clinical data from all infants born in 2017 and referred for ROP screening (NEDROP-2 study). Cost and effects of screening strategies were evaluated that d... Of the possible efficient strategies, the annual costs varied from €137 966 (inclusion of BW < 700, 63 infants eligible for screening, detection of 17/39 treated ROP) to €492 689 (GA < 30 weeks and BW... The current Dutch ROP guideline can be improved by implementing new screening inclusion criteria. The most effective strategy detecting all severe and treated infants, reduces the number of screened i...

Who performs neonatal hip assessment: is there a cause for concern?

The UK falls behind other European countries in the early detection of developmental dysplasia of the hip (DDH) and screening strategies differ for early detection. Clinical detection of DDH is challe... This was a retrospective observational study assessing all babies born consecutively over a 14-week period in 2020. Record of each initial baby check was obtained from BadgerNet. Follow-up data on ult... 1037 babies were examined by 65 individual examiners representing 9 different healthcare professional groups. The range of examinations conducted per examiner was 1-97 with a median of 5.5 examination... In a system where so many examiners are involved in neonatal hip assessment, the experience is limited for most examiners. Currently high rates of late presentation of DDH are observed locally, which ...

The use of transcutaneous bilirubin nomograms for the prevention of bilirubin neurotoxicity in the neonates.

Although neonatal jaundice is a ubiquitous and predominantly benign phenomenon, the risk of neurotoxicity exists in a number of infants with unconjugated hyperbilirubinemia. Plotting bilirubin values ... TcB measurements were taken in infants at ages ranging from 0 to 96 postnatal hours. We then constructed hour-specific TcB nomograms from forehead and sternum measurements in infants who did not requi... We included 2,981 TcB measurements taken on the forehead and 2,977 measurements taken on the sternum in 301 White term newborn infants. We assessed the predictive abilities of the nomograms at six pos... The nomograms illustrate dermal bilirubin dynamics in White term neonates during the first 4 days of life. They may be useful tools to predict individualized risk of hyperbilirubinemia requiring treat...

Transcutaneous bilirubinometry for detecting jaundice in term or late preterm neonates.

The American Academy of Pediatrics and the Canadian Paediatric Society both advise that all newborns should undergo bilirubin screening before leaving the hospital, and this has become the standard pr... To evaluate the effectiveness of transcutaneous screening compared to visual inspection for hyperbilirubinemia to prevent the readmission of newborns (infants greater than 35 weeks' gestation) for pho... We searched CENTRAL, MEDLINE, Embase, CINAHL, ClinicalTrials.gov, ICTRP, and ISRCTN in June 2023. We also searched conference proceedings, and the reference lists of included studies.... We included randomized controlled trials (RCTs), quasi-randomized, cluster-randomized, or prospective cohort studies with control arm that evaluated the use of transcutaneous bilirubin (TcB) screening... We used standard methodologic procedures expected by Cochrane. We evaluated treatment effects using a fixed-effect model with risk ratio (RR) and 95% confidence intervals (CI) for categorical data and... We identified one RCT (1858 participants) that met our inclusion criteria. The study included 1858 African newborns at 35 weeks' gestation or greater who were receiving routine care at a well-baby nur... Moderate-certainty evidence suggests that TcB screening may reduce readmission for hyperbilirubinemia compared to visual inspection. Low-certainty evidence also suggests that TcB screening probably ha...